Valuation: Formycon AG

Market Cap 33Cr 37Cr 31Cr 28Cr 52Cr 3.53TCr 53Cr 369.38Cr 146.7Cr 1.85TCr 139.55Cr 136.57Cr 5.87TCr P/E 2026 *
581x
P/E 2027 * 14.3x
Enterprise Value 45Cr 50Cr 41Cr 37Cr 70Cr 4.74TCr 71Cr 495.8Cr 196.9Cr 2.48TCr 187.31Cr 183.3Cr 7.88TCr EV / Sales 2026 *
6.16x
EV / Sales 2027 * 3.99x
Free-Float
69.59%
Yield 2026 *
-
Yield 2027 * -
1 day+1.69%
1 week-1.43%
Current month-0.31%
1 month+1.80%
3 months+2.01%
6 months+6.99%
Current year-24.69%
1 week 18.82
Extreme 18.82
19.66
1 month 18.3
Extreme 18.3
22.1
Current year 15.8
Extreme 15.8
26.95
1 year 15.8
Extreme 15.8
26.95
3 years 15.8
Extreme 15.8
67.8
5 years 15.8
Extreme 15.8
94.1
10 years 14.65
Extreme 14.65
94.1
Manager TitleAgeSince
Chief Executive Officer - 01/07/2022
Director of Finance/CFO 57 01/04/2023
Chief Tech/Sci/R&D Officer - 01/07/2022
Director TitleAgeSince
Director/Board Member 49 10/12/2020
Chairman 54 12/06/2024
Director/Board Member 54 12/06/2024
Date Insider Type Main position Quantity % Market Cap. Importance
21/02/25 Buy

Chief Technology Officer

160 0.0009%
29/04/24 Buy

Executive/Senior Manager

1,200 0.0068%
24/04/24 Buy

Chief Executive Officer

2,500 0.0142%
Change 5-day change 1-year change 3-year change Capi.($)
+1.69%-1.43%-14.69%-64.36% 37Cr
+0.65%-3.56%+33.53%+60.50% 6.35TCr
+1.61%+1.17%+11.71%+81.94% 5.45TCr
-1.09%+0.77%+10.21%+101.73% 5.36TCr
+1.82%+0.64%+27.63%+57.15% 4.48TCr
+2.19%-3.12%+18.16%+100.63% 4.16TCr
-0.06%-3.82%+221.23%+918.31% 3.99TCr
+0.64%-3.85%+11.71%+45.57% 3.25TCr
+29.06%+47.63%+107.12%+94.27% 2.67TCr
+3.72%-7.45%+24.25%-2.99% 2.34TCr
Average +4.02%-0.45%+45.09%+139.27% 3.81TCr
Weighted average by Cap. +2.95%-0.29%+47.11%+160.35%

Financials

2026 *2027 *
Net sales 7.27Cr 8.1Cr 6.71Cr 6.08Cr 11Cr 768.94Cr 12Cr 80Cr 32Cr 403.05Cr 30Cr 30Cr 1.28TCr 11Cr 12Cr 10Cr 9.38Cr 18Cr 1.19TCr 18Cr 124.04Cr 49Cr 621.56Cr 47Cr 46Cr 1.97TCr
Net income 6L 7L 5L 5L 9L 6.28Cr 9L 65.65L 26.07L 3.29Cr 24.8L 24.27L 10Cr 2.32Cr 2.58Cr 2.14Cr 1.94Cr 3.63Cr 245.43Cr 3.67Cr 26Cr 10Cr 128.65Cr 9.7Cr 9.49Cr 407.95Cr
Net Debt 11Cr 13Cr 11Cr 9.56Cr 18Cr 1.21TCr 18Cr 126.42Cr 50Cr 633.47Cr 48Cr 47Cr 2.01TCr 11Cr 13Cr 10Cr 9.5Cr 18Cr 1.2TCr 18Cr 125.54Cr 50Cr 629.06Cr 47Cr 46Cr 1.99TCr
Projected Income Statement - Annual - Formycon AG
Logo Formycon AG
Formycon AG is a Germany based Company. The Company is engaged in providing biosimilar drugs and formulations. The Company focuses on treatments in ophthalmology, immunology and other chronic diseases, covering all steps of biosimilar development process, from early-stage analysis of the originator drug to the preclinical and clinical testing phases, as well as the preparation of dossiers for marketing approval.
Employees
196
Date Price Change Volume
28/26/28 €19.28 +2.12% 1,290
27/26/27 €18.88 -0.11% 903
26/26/26 €18.90 +0.32% 888
23/26/23 €18.84 -0.74% 2,790
22/26/22 €18.98 -2.97% 2,263
Trader
Investor
-
Global
-
Quality
ESG MSCI
B
MarketScreener Ratings - Formycon AG
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
18.88EUR
Average target price
40.67EUR
Spread / Average Target
+115.40%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Formycon AG